Bostica

In June 2026, Bostica’s mix concentrated further into Flower at 76.96% share despite a -16.61% year-over-year decline and a 42.25% month-over-month rebound, while Pre-Roll rose to 18.61% share with 33.06% YoY growth and 42.91% MoM expansion. Vapor Pens held 3.08% share with 17.46% YoY and 16.45% MoM gains, whereas Concentrates slipped to 1.35% share on a -25.87% MoM drop and no reportable YoY trend. Average price fell -3.37% YoY to $18.95 even as Flower carried a higher category price of $20.20, implying mix and price-pressure effects working in opposite directions. The pattern implies Bostica is leaning into volume-led recovery in Flower and Pre-Roll to offset an -8.17% brand-level YoY sales decline while consolidating away from smaller niches.

Bostica’s 10th rank in Flower in Massachusetts, combined with a 42.25% MoM Flower surge and 42.91% MoM Pre-Roll lift, suggests near-term shelf velocity is concentrated in value-leaning formats as average price declines -3.37% YoY and Vapor Pens grows 17.46% YoY from a 3.08% share base. The -16.61% YoY contraction in Flower alongside a 33.06% YoY rise in Pre-Roll indicates substitution within inhalables rather than net category expansion, tilting positioning toward accessible Flower dominance with Pre-Roll as the growth wedge. The pattern implies Bostica’s competitive footing will be won by defending a top-10 Flower slot while harvesting incremental share from Pre-Roll, using price architecture to trade shoppers across the two rather than pushing into smaller, more volatile niches like Concentrates (-25.87% MoM).